Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Singh, Ritu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792819/
https://www.ncbi.nlm.nih.gov/pubmed/35118024
http://dx.doi.org/10.12997/jla.2022.11.1.84
_version_ 1784640461776879616
author Singh, Awadhesh Kumar
Singh, Ritu
author_facet Singh, Awadhesh Kumar
Singh, Ritu
author_sort Singh, Awadhesh Kumar
collection PubMed
description
format Online
Article
Text
id pubmed-8792819
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Society of Lipidology and Atherosclerosis
record_format MEDLINE/PubMed
spelling pubmed-87928192022-02-02 Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis” Singh, Awadhesh Kumar Singh, Ritu J Lipid Atheroscler Letter to the Editor Korean Society of Lipidology and Atherosclerosis 2022-01 2021-11-26 /pmc/articles/PMC8792819/ /pubmed/35118024 http://dx.doi.org/10.12997/jla.2022.11.1.84 Text en Copyright © 2022 The Korean Society of Lipid and Atherosclerosis. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Singh, Awadhesh Kumar
Singh, Ritu
Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
title Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
title_full Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
title_fullStr Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
title_full_unstemmed Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
title_short Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
title_sort letter by awadhesh kumar singh regarding article, “cardiovascular outcomes comparison of dipeptidyl peptidase-4 inhibitors versus sulfonylurea as add-on therapy for type 2 diabetes mellitus: a meta-analysis”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792819/
https://www.ncbi.nlm.nih.gov/pubmed/35118024
http://dx.doi.org/10.12997/jla.2022.11.1.84
work_keys_str_mv AT singhawadheshkumar letterbyawadheshkumarsinghregardingarticlecardiovascularoutcomescomparisonofdipeptidylpeptidase4inhibitorsversussulfonylureaasaddontherapyfortype2diabetesmellitusametaanalysis
AT singhritu letterbyawadheshkumarsinghregardingarticlecardiovascularoutcomescomparisonofdipeptidylpeptidase4inhibitorsversussulfonylureaasaddontherapyfortype2diabetesmellitusametaanalysis

Ejemplares similares